Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.50 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 8/20 | 0.46 |
| ▸ | MAOB | P27338 | 8/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.44 |
| ▸ | PARP1 | P09874 | 3/20 | 0.43 |
| ▸ | AOC2 | O75106 | 5/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8471197 | 1.00 | BRD4 (0.50) | BRD4CREBBPTDP1MAOAMAOB | |
| SCHEMBL8470150 | 1.00 | BRD4 (0.50) | BRD4CREBBPTDP1MAOAMAOB | |
| SCHEMBL11381215 | 0.78 | MAOA (0.37) | BRD4CREBBPMAOAMAOBCHRM2 | |
| SCHEMBL799675 | 0.78 | CA2 (0.44) | BRD4CREBBPCHRM2CHRM4CHRM5 | |
| SCHEMBL16429469 | 0.78 | CA2 (0.44) | BRD4CREBBPCHRM2CHRM4CHRM5 | |
| SCHEMBL8504530 | 0.78 | CHRM2 (0.41) | BRD4CREBBPMAOAMAOBCHRM2 | |
| SCHEMBL155647 | 0.78 | CA2 (0.44) | BRD4CREBBPCHRM2CHRM4CHRM5 | |
| SCHEMBL17167266 | 0.78 | CA2 (0.44) | BRD4CREBBPCHRM2CHRM4CHRM5 | |
| SCHEMBL7313976 | 0.75 | AOC2 (0.41) | BRD4CREBBPMAOAMAOBCHRM2 | |
| SCHEMBL8507467 | 0.75 | NISCH (0.42) | BRD4CREBBPTDP1MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108475728-B | Composition for manufacturing organic semiconductor device | 株式会社大赛璐 | 2023-04-18 | — | — | CN | claimed |
| US-20230010299-A1 | HETEROCYCLIC TRPML1 AGONISTS | LIBRA THERAPEUTICS, INC. | 2023-01-12 | — | — | US | claimed |
| CN-112760109-A | Method for comprehensively utilizing waste computer circuit boards through microwave pyrolysis | 楚雄滇中有色金属有限责任公司 | 2021-05-07 | — | — | CN | claimed |
| US-10717886-B2 | Ink composition, method for producing organic semiconductor element, organic semiconductor device, and method for producing optical element | SEIKO EPSON CORPORATION (JP) | 2020-07-21 | — | — | US | claimed |
| CN-105659404-B | Solvent for manufacturing organic transistor | 株式会社大赛璐 | 2020-02-07 | — | — | CN | claimed |
| CN-109516923-A | Compounds and organic luminescent device comprising it | 东进世美肯株式会社 | 2019-03-26 | — | — | CN | claimed |
| CN-105017188-B | A method of synthesis 3- halogen methyl -2,3- Dihydrobenzofuranes class compound | 福州大学 | 2019-03-05 | — | — | CN | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20190006603-A1 | COMPOSITION FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE | DAICEL CORPORATION (JP) | 2019-01-03 | — | — | US | claimed |
| EP-3396727-A1 | COMPOSITION FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE | Daicel Corporation (JP) | 2018-10-31 | — | — | EP | claimed |
| CN-108475728-A | Composition for manufacturing organic semiconductor device | 株式会社大赛璐 | 2018-08-31 | — | — | CN | claimed |
| US-20180030296-A1 | INK COMPOSITION, METHOD FOR PRODUCING ORGANIC SEMICONDUCTOR ELEMENT, ORGANIC SEMICONDUCTOR DEVICE, AND METHOD FOR PRODUCING OPTICAL ELEMENT | SEIKO EPSON CORPORATION (JP) | 2018-02-01 | — | — | US | claimed |
| EP-2488510-B1 | Amides and thioamides as pest control agents | BAYER IP GMBH (DE) | 2017-03-29 | — | — | EP | claimed |
| US-20130072471-A1 | Inhibitors of Ion Channels | MARRON BRIAN EDWARD (US) | 2013-03-21 | — | — | US | claimed |
| EP-1995241-B1 | Inhibitors of ion channels | ICAGEN INC (US) | 2010-03-17 | — | — | EP | claimed |
| US-20090143358-A1 | INHIBITORS OF ION CHANNELS | ICAGEN, INC. (US) | 2009-06-04 | — | — | US | claimed |
| EP-1995241-A1 | Inhibitors of ion channels | ICAgen, Incorporated (US) | 2008-11-26 | — | — | EP | claimed |
| WO-2008118758-A1 | INHIBITORS OF ION CHANNELS | ICAGEN, INC. (GB) | 2008-10-02 | — | — | WO | claimed |
| CN-1047595-C | Aminocoumaran derivatives, process for their preparation and their use as medicaments | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-12-22 | — | — | CN | claimed |
| WO-1998002435-A1 | NOVEL BENZODIOXANES AND 1-(2H)-BENZOPYRANES, THEIR PREPARATION AND THEIR USE AS MEDICINE | PIERRE FABRE MEDICAMENT (FR) | 1998-01-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072471-A1 | Inhibitors of Ion Channels | TRPV1, TRPV5, TRPA1 | BRD4 835/4885CREBBP 2883/4885TDP1 4420/4885 |
| US-20090143358-A1 | INHIBITORS OF ION CHANNELS | TRPV1, TRPV5, TRPA1 | BRD4 835/4885CREBBP 2883/4885TDP1 4420/4885 |
| US-20230010299-A1 | HETEROCYCLIC TRPML1 AGONISTS | TRPM7, TRPM2, TRPM5 | BRD4 2202/4885CREBBP 3232/4885TDP1 3364/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | BRD4 4882/4885CREBBP 4114/4885TDP1 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.